FDA Approval Activities for this Drug…

Orfadin (Nitisinone) Capsules, Swedish Orphan, (R&R Registration is the U.S. Agent NDA 21-232 1/18/02 2/5/02 2/5/02 2/28/02 Orfadin Indications: An adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia tyep 1.

For the latest approval information and links for this API, please see the main page.